The characteristics of arterial risk factors and ankle-brachial index in patients with lower extremity chronic venous diseases: results from the BEST study.

IF 1.5 4区 医学 Q3 PERIPHERAL VASCULAR DISEASE International Angiology Pub Date : 2024-04-01 Epub Date: 2024-04-12 DOI:10.23736/S0392-9590.24.05142-3
Shangtong Jiang, Yue Liu, Jinbo Liu, Gaoqiang Xie, Hongwei Zhao, Na Zhao, Hongyu Wang
{"title":"The characteristics of arterial risk factors and ankle-brachial index in patients with lower extremity chronic venous diseases: results from the BEST study.","authors":"Shangtong Jiang, Yue Liu, Jinbo Liu, Gaoqiang Xie, Hongwei Zhao, Na Zhao, Hongyu Wang","doi":"10.23736/S0392-9590.24.05142-3","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>The aim of our study was to explore the characteristics of the arterial risk factors and ankle-brachial index (ABI) in patients with lower extremity chronic venous disease (LECVD).</p><p><strong>Methods: </strong>A total of 2642 subjects were employed in our study. The lifestyle and clinical data were collected. The history of vascular diseases contained coronary artery disease, stroke, hypertension, and diabetes. ABI low than 0.9 was considered as lower extremity artery disease (LEAD). A series of blood indicators were measured.</p><p><strong>Results: </strong>Patients with ABI low than 0.9 belonged to the group of LEAD. Age, smoking, drinking, hypertension, diabetes mellitus, lipid-lowering drug, antidiabetic, total protein, total protein, triglyceride, low-density lipoprotein cholesterol, glycosylated hemoglobin and homocysteine were the common risk factors shared by LEAD and LECVD (P<0.05). The prevalence of LEAD in patients with LECVD was higher than those without LECVD (P<0.05). In Pearson correlation analysis, LECVD was related to LEAD (P<0.05). Before and after adjusted shared factors, as the performance of the logistic regression models, LEAD was an independent risk factor for the prevalence of LECVD (OR=2.937, 95% CI: [1.956, 4.411], P<0.001).</p><p><strong>Conclusions: </strong>Our study demonstrated that an ABI lower than 0.9 is an independent risk factor for LECVD.</p>","PeriodicalId":13709,"journal":{"name":"International Angiology","volume":" ","pages":"240-246"},"PeriodicalIF":1.5000,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Angiology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.23736/S0392-9590.24.05142-3","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/4/12 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"PERIPHERAL VASCULAR DISEASE","Score":null,"Total":0}
引用次数: 0

Abstract

Background: The aim of our study was to explore the characteristics of the arterial risk factors and ankle-brachial index (ABI) in patients with lower extremity chronic venous disease (LECVD).

Methods: A total of 2642 subjects were employed in our study. The lifestyle and clinical data were collected. The history of vascular diseases contained coronary artery disease, stroke, hypertension, and diabetes. ABI low than 0.9 was considered as lower extremity artery disease (LEAD). A series of blood indicators were measured.

Results: Patients with ABI low than 0.9 belonged to the group of LEAD. Age, smoking, drinking, hypertension, diabetes mellitus, lipid-lowering drug, antidiabetic, total protein, total protein, triglyceride, low-density lipoprotein cholesterol, glycosylated hemoglobin and homocysteine were the common risk factors shared by LEAD and LECVD (P<0.05). The prevalence of LEAD in patients with LECVD was higher than those without LECVD (P<0.05). In Pearson correlation analysis, LECVD was related to LEAD (P<0.05). Before and after adjusted shared factors, as the performance of the logistic regression models, LEAD was an independent risk factor for the prevalence of LECVD (OR=2.937, 95% CI: [1.956, 4.411], P<0.001).

Conclusions: Our study demonstrated that an ABI lower than 0.9 is an independent risk factor for LECVD.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
下肢慢性静脉疾病患者的动脉危险因素和踝肱指数特征:BEST 研究结果。
研究背景我们的研究旨在探讨下肢慢性静脉疾病(LECVD)患者的动脉危险因素和踝肱指数(ABI)的特征:方法:本研究共纳入 2642 名受试者。方法:我们共对 2642 名受试者进行了研究,收集了他们的生活方式和临床数据。血管疾病史包括冠心病、中风、高血压和糖尿病。ABI低于0.9为下肢动脉疾病(LEAD)。测量了一系列血液指标:结果:ABI 低于 0.9 的患者属于 LEAD 组。年龄、吸烟、饮酒、高血压、糖尿病、降脂药、抗糖尿病药、总蛋白、总蛋白、甘油三酯、低密度脂蛋白胆固醇、糖化血红蛋白和同型半胱氨酸是 LEAD 和 LECVD 的共同危险因素:我们的研究表明,ABI 低于 0.9 是导致 LECVD 的独立危险因素。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
International Angiology
International Angiology 医学-外周血管病
CiteScore
2.80
自引率
28.60%
发文量
89
审稿时长
6-12 weeks
期刊介绍: International Angiology publishes scientific papers on angiology. Manuscripts may be submitted in the form of editorials, original articles, review articles, special articles, letters to the Editor and guidelines. The journal aims to provide its readers with papers of the highest quality and impact through a process of careful peer review and editorial work. Duties and responsibilities of all the subjects involved in the editorial process are summarized at Publication ethics. Manuscripts are expected to comply with the instructions to authors which conform to the Uniform Requirements for Manuscripts Submitted to Biomedical Editors by the International Committee of Medical Journal Editors (ICMJE).
期刊最新文献
The rheolytic thrombectomy AngioJet™ is a safe and technically feasible method for treating acute and sub-acute occluding lesions in the visceral arteries. Midterm results after FEVAR and open surgery for infrarenal aortic aneurysms with short proximal necks: systematic review with meta-analysis of comparative studies. Saphenous vein versus synthetic graft in arteriovenous fistula for hemodialysis in patient with inaccessible veins. Characteristics and percutaneous transluminal angioplasty treatment outcomes of superior vena cava obstruction in patients undergoing hemodialysis. Glycocalyx disruption, endothelial dysfunction and vascular remodeling as underlying mechanisms and treatment targets of chronic venous disease.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1